Related links

Connection supplemental articles and policies - September 2008

Download the print version

Connection - Sept. 2008 (pdf, 153 KB)

supplemental articles


policies and forms

The following policies are new:

The following policies have been reviewed and changes are indicated on each policy:


It Fits! adds skiing to reimbursement list

Since we introduced it in 2004, It Fits! has garnered attention as an innovative program to get FCHP members active. This fitness reimbursement program has evolved over the years into a way for the entire family to get involved with aerobic activity. We’ve received positive feedback from employers, members and physicians regarding the program’s last expansion, which included activities such as school and town sports programs, dance lessons, gymnastics, karate, swimming lessons and much more. 

This year, as winter looms, FCHP is pleased to announce that we’re expanding It Fits! again. Our members may now be reimbursed for daily and seasonal ski lift passes and ski lessons, and we’re asking you to help us spread the word! If you have an FCHP member who is an avid skier, or someone who is new to the sport, let them know that they may now be reimbursed up to $300* for ski lift passes and lessons.

If you have any questions about our It Fits! program, please contact Provider Relations at 1-866-275-3247, option 4.

* Benefits may vary by product and employer


Chantix: Wondering about the "wonder drug?"

By T.J. Sweeney, Tobacco Treatment Specialist and team leader of the Quit Coaches with FCHP’s Quit to Win program

The harm tobacco causes doesn’t change much from year to year, nor does the soaring cost of treating tobacco-related medical conditions. So it’s no wonder that in the past two years a new tobacco-treatment medication has attracted a lot of attention.

Perhaps you were interested in Chantix® (varenicline) because you heard that it yielded higher quit rates than any other medication in clinical trials. Anecdotally, we’ve seen many people succeed at quitting with Chantix after several unsuccessful attempts by other methods. For some quitters, it really does seem to be the silver bullet that finally slays the tobacco monster.

Or, perhaps you’re more keenly aware of Chantix because of the negative press that’s been raised over concerns of suicidal ideation or other potentially serious health concerns.

Chantix’s approval was “fast-tracked” by the FDA when it came to market in August 2006. Had it been held back a couple of years, we may have become skeptical after hearing warnings of increasing suicidal thoughts in patients using Chantix.

However, with approximately 5 million Chantix users, some experts have questioned whether or not the rate of suicidal thoughts reported by Chantix users is significantly different from the rate of suicidal thoughts in 5 million non-users. Recently, the Veteran’s Administration was criticized for sending late-warning letters to its 30,000 Chantix users. The VA noted, however, that its observations showed the rate of suicidal ideation among those Chantix users was much lower than reports among veterans not using Chantix! Since every medication may cause side effects in some users, we might ask how the known risks of continuing to smoke compare to the potential side effects of Chantix.

In whatever way you decide to help your patients quit, you’ll feel better knowing they are under the trained and compassionate care of one of our Quit Coaches. And, if they are FCHP members, they’re eligible to participate in our Quit to Win program free of charge. Statistics show that people who participate in a weekly program while quitting are measurably more successful than people who quit on their own. FCHP’s program is one of the most successful quit-smoking programs in the country.

If we can be of assistance to you, your staff or your patients, we hope you’ll contact us by e-mail at QuitToWin@fchp.org; by phone at 1-888-807-2908; or by fax at 1-508-798-8394.


Formulary updates

Fallon Community Health Plan often makes changes to its formularies, including changing prior authorization requirements and adding new medications. Please note the following changes to our commercial plan formulary.

Commercial plan formulary

Additions
Anestafoam® (lidocaine)   Tier 3
EvaMist® (estradiol transdermal)   Tier 3
Dazidox® (oxycodone)  Tier 3
Fenoglide® (fenofibrate) Tier 3
Isentress® (raltegravir)  Tier 3
Letairis® (ambrisentan)  Tier 3, PA required
Lybrel® (levonorgestrel/ethinyl estradiol) Tier 3
Simcor® (niacin/simvastatin) Tier 3
Tekturna HCT® (aliskiren/HCTZ)     Tier 3, PA required

New to market policy*

Intelence™ (etravirine)

* FCHP’s New to Market Policy was enacted to ensure patient safety and to allow for adequate time for the development, review and approval of clinical criteria. When a new medication first becomes available, it will fall under this policy and be excluded from coverage. A process is in place that allows for the quick review of provider requests for noncovered pharmaceuticals.

Medicare Part D formulary

Additions

DRUG DESCRIPTION

STATUS

ACARBOSE 100 MG TABS

Added as Tier 1

ACARBOSE 25 MG TABS

Added as Tier 1

ACARBOSE 50 MG TABS

Added as Tier 1

ACTONEL 150 MG TABS

Added as Tier 3, QL 1 per 30 days

CALCIPOTRIENE 0.005 % SOLN

Added as Tier 1

CLOBETASOL PROPIONATE 0.05 % FOAM

Added as Tier 1, PA required

ESTRADIOL/NORETHINDRONE A 1 MG,0.5 MG TABS

Added as Tier 1

FLUOROURACIL 5 % CREA

Added as Tier 1

LOCOID 0.1 % LOTN

Added as Tier 3

OMNARIS 50 MCG/ACT SUSP

Added as Tier 3

PAROXETINE HCL ER 12.5 MG TB24

Added as Tier 1

PAROXETINE HCL ER 25 MG TB24

Added as Tier 1

PATANASE 0.6 % SOLN

Added as Tier 3

PULMICORT 1 MG/2ML SUSP

Added as Tier 3, PA required

RAMIPRIL 1.25 MG CAPS

Added as Tier 1

RIBAVIRIN 500 MG TABS

Added as Tier 1, PA required

ROPINIROLE HCL 0.25 MG TABS

Added as Tier 1

ROPINIROLE HCL 0.5 MG TABS

Added as Tier 1

ROPINIROLE HCL 1 MG TABS

Added as Tier 1

ROPINIROLE HCL 2 MG TABS

Added as Tier 1

ROPINIROLE HCL 3 MG TABS

Added as Tier 1

ROPINIROLE HCL 4 MG TABS

Added as Tier 1

ROPINIROLE HCL 5 MG TABS

Added as Tier 1

SULAR 17 MG TB24

Added as Tier 3

SULAR 25.5 MG TB24

Added as Tier 3

SULAR 34 MG TB24

Added as Tier 3

SULAR 8.5 MG TB24

Added as Tier 3

VOLTAREN 1 % GEL

Added as Tier 3

 

New ICD-9-CM codes available

The annual update of the ICD-9-CM diagnosis and procedure codes is effective for dates of service on or after October 1, 2008. An ICD-9-CM diagnosis code is required on all paper and electronic claims billed to Fallon Community Health Plan. Below is a list of new ICD-9-CM codes.

ICD-9 Procedure Code

Description

00.49

SUPERSATURATED OXYGEN THERAPY

00.58

INSERTION OF INTRA-ANEURYSM SAC PRESSURE MONITORING DEVICE (INTRAOPERATIVE)

00.59

INTRAVASCULAR PRESSURE MEASUREMENT OF CORONARY ARTERIES

00.67

INTRAVASCULAR PRESSURE MEASUREMENT OF INTRATHORACIC ARTERIES

00.68

INTRAVASCULAR PRESSURE MEASUREMENT OF PERIPHERAL ARTERIES

00.69

INTRAVASCULAR PRESSURE MEASUREMENT, OTHER SPECIFIED AND UNSPECIFIED VESSELS

17.

ABDOMEN/COLON LAPAROSCOPIC PROCEDURES

17.1

UNILATERAL LAPAROSCOPIC INGUINAL HERNIA REPAIR

17.11

LAPAROSCOPIC REPAIR OF DIRECT INGUINAL HERNIA WITH GRAFT OR PROSTHESIS

17.12

LAPAROSCOPIC REPAIR OF INDIRECT INGUINAL HERNIA WITH GRAFT OR PROSTHESIS

17.13

LAPAROSCOPIC REPAIR OF INGUINAL HERNIA WITH GRAFT OR PROSTHESIS, NOT OTHERWISE SPECIFIED

17.2

BILATERAL LAPAROSCOPIC INGUINAL HERNIA REPAIR

17.21

LAPAROSCOPIC BILATERAL REPAIR OF DIRECT INGUINAL HERNIA WITH GRAFT OR PROSTHESIS

17.22

LAPAROSCOPIC BILATERAL REPAIR OF INDIRECT INGUINAL HERNIA WITH GRAFT OR PROSTHESIS

17.23

LAPAROSCOPIC BILATERAL REPAIR OF INGUINAL HERNIA, ONE DIRECT AND ONE INDIRECT, WITH GRAFT OR PROSTHESIS

17.24

LAPAROSCOPIC BILATERAL REPAIR OF INGUINAL HERNIA WITH GRAFT OR PROSTHESIS, NOT OTHERWISE SPECIFIED

17.3

LAPAROSCOPIC COLON PROCEDURES

17.31

LAPAROSCOPIC MULTIPLE SEGMENTAL RESECTION OF LARGE INTESTINE

17.32

LAPAROSCOPIC CECECTOMY INTESTINE

17.33

LAPAROSCOPIC RIGHT HEMICOLECTOMY

17.34

LAPAROSCOPIC RESECTION OF TRANSVERSE COLON

17.35

LAPAROSCOPIC LEFT HEMICOLECTOMY

17.36

LAPAROSCOPIC SIGMOIDECTOMY

17.39

OTHER LAPAROSCOPIC PARTIAL EXCISION OF LARGE INTESTINE

37.36

EXCISION OR DESTRUCTION OF LEFT ATRIAL APPENDAGE (LAA)

37.55

REMOVAL OF INTERNAL BIVENTRICULAR HEART REPLACEMENT SYSTEM

38.23

INTRAVASCULAR SPECTROSCOPY

45.81

LAPAROSCOPIC TOTAL INTRA-ABDOMINAL COLECTOMY

45.82

OPEN TOTAL INTRA-ABDOMINAL COLECTOMY

45.83

OTHER AND UNSPECIFIED TOTAL INTRA-ABDOMINAL COLECTOMY

48.40

PULL-THROUGH RESECTION OF RECTUM, NOT OTHERWISE SPECIFIED

48.42

LAPAROSCOPIC PULL-THROUGH RESECTION OF RECTUM

48.43

OPEN PULL-THROUGH RESECTION OF RECTUM

48.50

ABDOMINOPERINEAL RESECTION OF THE RECTUM, NOT OTHERWISE SPECIFIED

48.51

LAPAROSCOPIC ABDOMINOPERINEAL RESECTION OF THE RECTUM

48.52

OPEN ABDOMINOPERINEAL RESECTION OF THE RECTUM

48.59

OTHER ABDOMINOPERINEAL RESECTION OF THE RECTUM

53.42

LAPAROSCOPIC REPAIR OF UMBILICAL HERNIA WITH GRAFT OR PROSTHESIS

53.43

OTHER LAPAROSCOPIC UMBILICAL HERNIORRHAPHY

53.62

LAPAROSCOPIC INCISIONAL HERNIA REPAIR WITH GRAFT OR PROSTHESIS

53.63

OTHER LAPAROSCOPIC REPAIR OF OTHER HERNIA OF ANTERIOR ABDOMINAL WALL WITH GRAFT OR PROSTHESIS

53.71

LAPAROSCOPIC REPAIR OF DIAPHRAGMATIC HERNIA, ABDOMINAL APPROACH

53.72

OTHER AND OPEN REPAIR OF DIAPHRAGMATIC HERNIA, ABDOMINAL APPROACH

53.75

REPAIR OF DIAPHRAGMATIC HERNIA, ABDOMINAL APPROACH, NOT OTHERWISE SPECIFIED

53.83

LAPAROSCOPIC REPAIR OF DIAPHRAGMATIC HERNIA, WITH THORACIC APPROACH

53.84

OTHER AND OPEN REPAIR OF DIAPHRAGMATIC HERNIA, WITH THORACIC APPROACH

55.32

OPEN ABLATION OF RENAL LESION OR TISSUE

55.33

PERCUTANEOUS ABLATION OF RENAL LESION OR TISSUE

55.34

LAPAROSCOPIC ABLATION OF RENAL LESION OR TISSUE

55.35

OTHER AND UNSPECIFIED ABLATION OF RENAL LESION OR TISSUE

80.53

REPAIR OF THE ANULUS FIBROSUS WITH GRAFT OR PROSTHESIS

80.54

OTHER AND UNSPECIFIED REPAIR OF THE ANULUS FIBROSUS

89.16

TRANSILLUMINATION OF NEWBORN SKULL

038.12

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS SEPTICEMIA

10/01/2008

041.12

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE

10/01/2008

046.11

VARIANT CREUTZFELDT-JAKOB DISEASE

10/01/2008

046.19

OTHER AND UNSPECIFIED CREUTZFELDT-JAKOB DISEASE

10/01/2008

046.7

OTHER SPECIFIED PRION DISEASES OF CENTRAL NERVOUS SYSTEM

10/01/2008

046.71

GERSTMANN-STRAUSSLER-SCHEINKER SYNDROME

10/01/2008

046.72

FETAL FAMILIAL INSOMNIA

10/01/2008

046.79

OTHER AND UNSPECIFIED PRION DISEASE OF CENTRAL NERVOUS SYSTEM

10/01/2008

051.01

COWPOX

10/01/2008

051.02

VACCINIA NOT FROM VACCINATION

10/01/2008

059

OTHER POXVIRUS INFECTIONS

10/01/2008

059.0

OTHER ORTHOPOXVIRUS INFECTIONS

10/01/2008

059.00

ORTHOPOXVIRUS INFECTION, UNSPECIFIED

10/01/2008

059.01

MONKEYPOX

10/01/2008

059.09

OTHER ORTHOPOXVIRUS INFECTION

10/01/2008

059.1

OTHER PARAPOXVIRUS INFECTIONS

10/01/2008

059.10

PARAPOXVIRUS INFECTION, UNSPECIFIED

10/01/2008

059.11

BOVINE STOMATITIS

10/01/2008

059.12

SEALPOX

10/01/2008

059.19

OTHER PARAPOXVIRUS INFECTIONS

10/01/2008

059.2

YATAPOXVIRUS INFECTIONS

10/01/2008

059.20

YATAPOXVIRUS INFECTION, UNSPECIFIED

10/01/2008

059.21

TANAPOX

10/01/2008

059.22

YABA MONKEY TUMOR VIRUS

10/01/2008

059.8

OTHER POXVIRUS INFECTIONS

10/01/2008

059.9

POXVIRUS INFECTIONS, UNSPECIFIED

10/01/2008

078.12

PLANTAR WART

10/01/2008

136.21

SPECIFIC INFECTION DUE TO ACANTHAMOEBA

10/01/2008

136.29

OTHER SPECIFIC INFECTIONS BY FREE-LIVING AMEBAE

10/01/2008

199.2

MALIGNANT NEOPLASM ASSOCIATED WITH TRANSPLANTED ORGAN

10/01/2008

203.02

MULTIPLE MYELOMA, IN RELAPSE

10/01/2008

203.12

PLASMA CELL LEUKEMIA, IN RELAPSE

10/01/2008

203.82

OTHER IMMUNOPROLIFERATIVE NEOPLASMS, IN RELAPSE

10/01/2008

204.02

LYMPHOID LEUKEMIA, ACUTE, IN RELAPSE

10/01/2008

204.12

LYMPHOID LEUKEMIA, CHRONIC, IN RELAPSE

10/01/2008

204.22

LYMPHOID LEUKEMIA, SUBACUTE, IN RELAPSE

10/01/2008

204.82

LYMPHOID LEUKEMIA, OTHER, IN RELAPSE

10/01/2008

204.92

LYMPHOID LEUKEMIA, UNSPECIFIED, IN RELAPSE

10/01/2008

205.02

MYELOID LEUKEMIA, ACUTE, IN RELAPSE

10/01/2008

205.12

MYELOID LEUKEMIA, CHRONIC, IN RELAPSE

10/01/2008

205.22

MYELOID LEUKEMIA, SUBACUTE, IN RELAPSE

10/01/2008

205.32

MYELOID SARCOMA, IN RELAPSE

10/01/2008

205.82

MYELOID LEUKEMIA, OTHER, IN RELAPSE

10/01/2008

205.92

MYELOID LEUKEMIA, UNSPECIFIED, IN RELAPSE

10/01/2008

206.02

MONOCYTIC LEUKEMIA, ACUTE, IN RELAPSE

10/01/2008

206.12

MONOCYTIC LEUKEMIA, CHRONIC, IN RELAPSE

10/01/2008

206.22

MONOCYTIC LEUKEMIA, SUBACUTE, IN RELAPSE

10/01/2008

206.82

MONOCYTIC LEUKEMIA, OTHER, IN RELAPSE

10/01/2008

206.92

MONOCYTIC LEUKEMIA, UNSPECIFIED, IN RELAPSE

10/01/2008

207.02

ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA, IN RELAPSE

10/01/2008

207.12

CHRONIC ERYTHREMIA, IN RELAPSE

10/01/2008

207.22

MEGAKARYOCYTIC LEUKEMIA, IN RELAPSE

10/01/2008

207.82

OTHER SPECIFIED LEUKEMIA, IN RELAPSE

10/01/2008

208.02

LEUKEMIA OF UNSPECIFIED CELL TYPE, ACUTE, IN RELAPSE

10/01/2008

208.12

LEUKEMIA OF UNSPECIFIED CELL TYPE, CHRONIC, IN RELAPSE

10/01/2008

208.22

LEUKEMIA OF UNSPECIFIED CELL TYPE, SUBACUTE, IN RELAPSE

10/01/2008

208.82

LEUKEMIA OF UNSPECIFIED CELL TYPE, OTHER, IN RELAPSE

10/01/2008

208.92

LEUKEMIA, UNSPECIFIED, IN RELAPSE

10/01/2008

209

NEUROENDOCRINE TUMORS

10/01/2008

209.0

MALIGNANT CARCINOID TUMORS OF THE SMALL INTESTINE

10/01/2008

209.00

MALIGNANT CARCINOID TUMOR OF THE SMALL INTESTINE, UNSPECIFIED PORTION

10/01/2008

209.01

MALIGNANT CARCINOID TUMOR OF THE DUODENUM

10/01/2008

209.02

MALIGNANT CARCINOID TUMOR OF THE JEJUNUM

10/01/2008

209.03

MALIGNANT CARCINOID TUMOR OF THE ILEUM

10/01/2008

209.1

MALIGNANT CARCINOID TUMORS OF THE APPENDIX, LARGE INTESTINE, AND RECTUM

10/01/2008

209.10

MALIGNANT CARCINOID TUMOR OF THE LARGE INTESTINE, UNSPECIFIED PORTION

10/01/2008

209.11

MALIGNANT CARCINOID TUMOR OF THE APPENDIX

10/01/2008

209.12

MALIGNANT CARCINOID TUMOR OF THE CECUM

10/01/2008

209.13

MALIGNANT CARCINOID TUMOR OF THE ASCENDING COLON

10/01/2008

209.14

MALIGNANT CARCINOID TUMOR OF THE TRANSVERSE COLON

10/01/2008

209.15

MALIGNANT CARCINOID TUMOR OF THE DESCENDING COLON

10/01/2008

209.16

MALIGNANT CARCINOID TUMOR OF THE SIGMOID COLON

10/01/2008

209.17

MALIGNANT CARCINOID TUMOR OF THE RECTUM

10/01/2008

209.2

MALIGNANT CARCINOID TUMORS OF OTHER AND UNSPECIFIED SITES

10/01/2008

209.20

MALIGNANT CARCINOID TUMOR OF UNKNOWN PRIMARY SITE

10/01/2008

209.21

MALIGNANT CARCINOID TUMOR OF THE BRONCHUS AND LUNG

10/01/2008

209.22

MALIGNANT CARCINOID TUMOR OF THE THYMUS

10/01/2008

209.23

MALIGNANT CARCINOID TUMOR OF THE STOMACH

10/01/2008

209.24

MALIGNANT CARCINOID TUMOR OF THE KIDNEY

10/01/2008

209.25

MALIGNANT CARCINOID TUMOR OF THE FOREGUT NOS

10/01/2008

209.26

MALIGNANT CARCINOID TUMOR OF THE MIDGUT NOS

10/01/2008

209.27

MALIGNANT CARCINOID TUMOR OF THE HINDGUT NOS

10/01/2008

209.29

MALIGNANT CARCINOID TUMORS OF OTHER SITES

10/01/2008

209.3

MALIGNANT POORLY DIFFERENTIATED NEUROENDOCRINE TUMORS

10/01/2008

209.30

MALIGNANT POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA, ANY SITE

10/01/2008

209.4

BENIGN CARCINOID TUMORS OF THE SMALL INTESTINE

10/01/2008

209.40

BENIGN CARCINOID TUMOR OF THE SMALL INTESTINE, UNSPECIFIED PORTION

10/01/2008

209.41

BENIGN CARCINOID TUMOR OF THE DUODENUM

10/01/2008

209.42

BENIGN CARCINOID TUMOR OF THE JEJUNUM

10/01/2008

209.43

BENIGN CARCINOID TUMOR OF THE ILEUM

10/01/2008

209.5

BENIGN CARCINOID TUMORS OF THE APPENDIX, LARGE INTESTINE, AND RECTUM

10/01/2008

209.50

BENIGN CARCINOID TUMOR OF THE LARGE INTESTINE, UNSPECIFIED PORTION

10/01/2008

209.51

BENIGN CARCINOID TUMOR OF THE APPENDIX

10/01/2008

209.52

BENIGN CARCINOID TUMOR OF THE CECUM

10/01/2008

209.53

BENIGN CARCINOID TUMOR OF THE ASCENDING COLON

10/01/2008

209.54

BENIGN CARCINOID TUMOR OF THE TRANSVERSE COLON

10/01/2008

209.55

BENIGN CARCINOID TUMOR OF THE DESCENDING COLON

10/01/2008

209.56

BENIGN CARCINOID TUMOR OF THE SIGMOID COLON

10/01/2008

209.57

BENIGN CARCINOID TUMOR OF THE RECTUM

10/01/2008

209.6

BENIGN CARCINOID TUMORS OF OTHER AND UNSPECIFIED SITES

10/01/2008

209.60

BENIGN CARCINOID TUMOR OF UNKNOWN PRIMARY SITE

10/01/2008

209.61

BENIGN CARCINOID TUMOR OF THE BRONCHUS AND LUNG

10/01/2008

209.62

BENIGN CARCINOID TUMOR OF THE THYMUS

10/01/2008

209.63

BENIGN CARCINOID TUMOR OF THE STOMACH

10/01/2008

209.64

BENIGN CARCINOID TUMOR OF THE KIDNEY

10/01/2008

209.65

BENIGN CARCINOID TUMOR OF THE FOREGUT NOS

10/01/2008

209.66

BENIGN CARCINOID TUMOR OF THE MIDGUT NOS

10/01/2008

209.67

BENIGN CARCINOID TUMOR OF THE HINDGUT NOS

10/01/2008

209.69

BENIGN CARCINOID TUMORS OF OTHER SITES

10/01/2008

238.77

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)

10/01/2008

249

SECONDARY DIABETES MELLITUS

10/01/2008

249.0

SECONDARY DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION

10/01/2008

249.00

SECONDARY DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.01

SECONDARY DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, UNCONTROLLED

10/01/2008

249.1

SECONDARY DIABETES MELLITUS WITH KETOACIDOSIS

10/01/2008

249.10

SECONDARY DIABETES MELLITUS WITH KETOACIDOSIS, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.11

SECONDARY DIABETES MELLITUS WITH KETOACIDOSIS, UNCONTROLLED

10/01/2008

249.2

SECONDARY DIABETES MELLITUS WITH HYPEROSMOLARITY

10/01/2008

249.20

SECONDARY DIABETES MELLITUS WITH HYPEROSMOLARITY, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.21

SECONDARY DIABETES MELLITUS WITH HYPEROSMOLARITY, UNCONTROLLED

10/01/2008

249.3

SECONDARY DIABETES MELLITUS WITH OTHER COMA

10/01/2008

249.30

SECONDARY DIABETES MELLITUS WITH OTHER COMA , NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.31

SECONDARY DIABETES MELLITUS WITH OTHER COMA , UNCONTROLLED

10/01/2008

249.4

SECONDARY DIABETES MELLITUS WITH RENAL MANIFESTATIONS

10/01/2008

249.40

SECONDARY DIABETES MELLITUS WITH RENAL MANIFESTATIONS, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.41

SECONDARY DIABETES MELLITUS WITH RENAL MANIFESTATIONS, UNCONTROLLED

10/01/2008

249.5

SECONDARY DIABETES MELLITUS WITH OPHTHALMIC MANIFESTATIONS

10/01/2008

249.50

SECONDARY DIABETES MELLITUS WITH OPHTHALMIC MANIFESTATIONS, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.51

SECONDARY DIABETES MELLITUS WITH OPHTHALMIC MANIFESTATIONS, UNCONTROLLED

10/01/2008

249.6

SECONDARY DIABETES MELLITUS WITH NEUROLOGICAL MANIFESTATIONS

10/01/2008

249.60

SECONDARY DIABETES MELLITUS WITH NEUROLOGICAL MANIFESTATIONS, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.61

SECONDARY DIABETES MELLITUS WITH NEUROLOGICAL MANIFESTATIONS, UNCONTROLLED

10/01/2008

249.7

SECONDARY DIABETES MELLITUS WITH PERIPHERAL CIRCULATORY DISORDERS

10/01/2008

249.70

SECONDARY DIABETES MELLITUS WITH PERIPHERAL CIRCULATORY DISORDERS, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.71

SECONDARY DIABETES MELLITUS WITH PERIPHERAL CIRCULATORY DISORDERS, UNCONTROLLED

10/01/2008

249.8

SECONDARY DIABETES MELLITUS WITH OTHER SPECIFIED MANIFESTATIONS

10/01/2008

249.80

SECONDARY DIABETES MELLITUS WITH OTHER SPECIFIED MANIFESTATIONS, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.81

SECONDARY DIABETES MELLITUS WITH OTHER SPECIFIED MANIFESTATIONS, UNCONTROLLED

10/01/2008

249.9

SECONDARY DIABETES MELLITUS WITH UNSPECIFIED COMPLICATION

10/01/2008

249.90

SECONDARY DIABETES MELLITUS WITH UNSPECIFIED COMPLICATION, NOT STATED AS UNCONTROLLED, OR UNSPECIFIED

10/01/2008

249.91

SECONDARY DIABETES MELLITUS WITH UNSPECIFIED COMPLICATION, UNCONTROLLED

10/01/2008

259.50

ANDROGEN INSENSITIVITY, UNSPECIFIED

10/01/2008

259.51

ANDROGEN INSENSITIVITY SYNDROME

10/01/2008

259.52

PARTIAL ANDROGEN INSENSITIVITY

10/01/2008

275.5

HUNGRY BONE SYNDROME

10/01/2008

279.5

GRAFT-VERSUS-HOST DISEASE

10/01/2008

279.50

GRAFT-VERSUS-HOST DISEASE, UNSPECIFIED

10/01/2008

279.51

GRAFT-VERSUS-HOST DISEASE, ACUTE

10/01/2008

279.52

GRAFT-VERSUS-HOST DISEASE, CHRONIC

10/01/2008

279.53

GRAFT-VERSUS-HOST DISEASE, ACUTE ON CHRONIC

10/01/2008

289.84

HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)

10/01/2008

337.00

IDIOPATHIC PERIPHERAL AUTONOMIC NEUROPATHY, UNSPECIFIED

10/01/2008

337.01

CAROTID SINUS SYNDROME

10/01/2008

337.09

OTHER IODIOPATHIC PERIPHERAL AUTONOMIC NEUROPATHY

10/01/2008

339

OTHER HEADACHE SYNDROMES

10/01/2008

339.0

CLUSTER HEADACHES AND OTHER TRIGEMINAL AUTONOMIC CEPHALGIAS

10/01/2008

339.00

CLUSTER HEADACHE SYNDROME, UNSPECIFIED

10/01/2008

339.01

EPISODIC CLUSTER HEADACHE

10/01/2008

339.02

CHRONIC CLUSTER HEADACHE

10/01/2008

339.03

EPISODIC PAROXYSMAL HEMICRANIA

10/01/2008

339.04

CHRONIC PAROXYSMAL HEMICRANIA

10/01/2008

339.05

SHORT LASTING UNILATERAL NEURALGIFORM HEADACHE WITH CONJUNCTIVAL INJECTION AND TEARING

10/01/2008

339.09

OTHER TRIGEMINAL AUTONOMIC CEPHALGIAS

10/01/2008

339.1

TENSION TYPE HEADACHE

10/01/2008

339.10

TENSION TYPE HEADACHE, UNSPECIFIED

10/01/2008

339.11

EPISODIC TENSION TYPE HEADACHE

10/01/2008

339.12

CHRONIC TENSION TYPE HEADACHE

10/01/2008

339.2

POST-TRAUMATIC HEADACHE

10/01/2008

339.20

POST-TRAUMATIC HEADACHE, UNSPECIFIED

10/01/2008

339.21

POST-TRAUMATIC HEADACHE, ACUTE

10/01/2008

339.22

POST-TRAUMATIC HEADACHE, CHRONIC

10/01/2008

339.3

DRUG INDUCED HEADACHE, NOT ELSEWHERE CLASSIFIED

10/01/2008

339.4

COMPLICATED HEADACHE SYNDROMES

10/01/2008

339.41

HEMICRANIA CONTINUA

10/01/2008

339.42

NEW DAILY PERSISTENT HEADACHE

10/01/2008

339.43

PRIMARY THUNDERCLAP HEADACHE

10/01/2008

339.44

OTHER COMPLICATED HEADACHE SYNDROME

10/01/2008

339.8

OTHER SPECIFIED HEADACHE SYNDROMES

10/01/2008

339.81

HYPNIC HEADACHE

10/01/2008

339.82

HEADACHE ASSOCIATED WITH SEXUAL ACTIVITY

10/01/2008

339.83

PRIMARY COUGH HEADACHE

10/01/2008

339.84

PRIMARY EXERTIONAL HEADACHE

10/01/2008

339.85

PRIMARY STABBING HEADACHE

10/01/2008

339.89

OTHER SPECIFIED HEADACHE SYNDROMES

10/01/2008

346.02

MIGRAINE WITH AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.03

MIGRAINE WITH AURA, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.12

MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.13

MIGRAINE WITHOUT AURA, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.22

VARIANTS OF MIGRAINE, NOT ELSEWHERE CLASSIFIED, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.23

VARIANTS OF MIGRAINE, NOT ELSEWHERE CLASSIFIED, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.3

HEMIPLEGIC MIGRAINE

10/01/2008

346.30

HEMIPLEGIC MIGRAINE, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.31

HEMIPLEGIC MIGRAINE, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.32

HEMIPLEGIC MIGRAINE, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.33

HEMIPLEGIC MIGRAINE, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.4

MENSTRUAL MIGRAINE

10/01/2008

346.40

MENSTRUAL MIGRAINE, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.41

MENSTRUAL MIGRAINE, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.42

MENSTRUAL MIGRAINE, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.43

MENSTRUAL MIGRAINE, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.5

PERSISTENT MIGRAINE AURA WITHOUT CEREBRAL INFARCTION

10/01/2008

346.50

PERSISTENT MIGRAINE AURA WITHOUT CEREBRAL INFARCTION, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.51

PERSISTENT MIGRAINE AURA WITHOUT CEREBRAL INFARCTION, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.52

PERSISTENT MIGRAINE AURA WITHOUT CEREBRAL INFARCTION, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.53

PERSISTENT MIGRAINE AURA WITHOUT CEREBRAL INFARCTION, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.6

PERSISTENT MIGRAINE AURA WITH CEREBRAL INFARCTION

10/01/2008

346.60

PERSISTENT MIGRAINE AURA WITH CEREBRAL INFARCTION, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.61

PERSISTENT MIGRAINE AURA WITH CEREBRAL INFARCTION, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.62

PERSISTENT MIGRAINE AURA WITH CEREBRAL INFARCTION, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.63

PERSISTENT MIGRAINE AURA WITH CEREBRAL INFARCTION, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.7

CHRONIC MIGRAINE WITHOUT AURA

10/01/2008

346.70

CHRONIC MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.71

CHRONIC MIGRAINE WITHOUT AURA, WITH INTRACTABLE MIGRAINE, SO STATED, WITHOUT MENTION OF STATUS MIGRAINOSUS

10/01/2008

346.72

CHRONIC MIGRAINE WITHOUT AURA, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.73

CHRONIC MIGRAINE WITHOUT AURA, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.82

OTHER FORMS OF MIGRAINE, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.83

OTHER FORMS OF MIGRAINE, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

346.92

MIGRAINE, UNSPECIFIED, WITHOUT MENTION OF INTRACTABLE MIGRAINE WITH STATUS MIGRAINOSUS

10/01/2008

346.93

MIGRAINE, UNSPECIFIED, WITH INTRACTABLE MIGRAINE, SO STATED, WITH STATUS MIGRAINOSUS

10/01/2008

349.3

DURAL TEAR

10/01/2008

349.31

ACCIDENTAL PUNCTURE OR LACERATION OF DURA DURING A PROCEDURE

10/01/2008

349.39

DURAL TEAR, OTHER

10/01/2008

362.20

RETINOPATHY OF PREMATURITY, UNSPECIFIED

10/01/2008

362.22

RETINOPATHY OF PREMATURITY, STATE 0

10/01/2008

362.23

RETINOPATHY OF PREMATURITY, STAGE 1

10/01/2008

362.24

RETINOPATHY OF PREMATURITY, STAGE 2

10/01/2008

362.25

RETINOPATHY OF PREMATURITY, STAGE 3

10/01/2008

362.26

RETINOPATHY OF PREMATURITY, STAGE 4

10/01/2008

362.27

RETINOPATHY OF PREMATURITY, STAGE 5

10/01/2008

364.82

PLATEAU IRIS SYNDROME

10/01/2008